16 October 09:14
The Novo Nordisk company is stopping the production of human insulin pen-type insulin syringes, affecting people with type 1 diabetes.
Călin Nicolescu
Health
Foto Pixabay
People with type 1 diabetes who depend on human insulin made by Novo Nordisk will instead be given glass vials and syringes - said to be inconvenient and harder to use with the same precision. Novo Nordisk has already stopped supply in South Africa, where patients have had to switch to glass vials. Novo Nordisk's decision is linked to its favoring of the marketing of the slimming drugs Ozempic and Wegovy.
Sources
O companie farmaceutică ar fi oprit producţia de seringi cu insulină pentru a vinde produse de slăbit
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk, compania producătoare de medicamente folosite pentru pierderea în greutate, acuzată că prioritizează profiturile după oprirea producției de stilouri cu insulină
ȘTIRI PE ACELEAȘI SUBIECTE
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
